Cite
HARVARD Citation
Lo, U. et al. (2022). The driver role of JAK‐STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy‐ and castration‐resistant prostate cancer. Clinical and translational medicine. 12 (8), p. n/a. [Online].